Company Overview
- Headquarters
- 2001 Market Street, Suite 3915, Unit 15, Philadelphia PA
- Website
- contexttherapeutics.com
- Phone
- (267) 225-7416
- Employees
- 13
- Founded in
- 2015
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$3B
Who is Context Therapeutics
Context Therapeutics Inc. is a privately held biopharmaceutical company headquartered in Philadelphia, Pennsylvania. The company employs thirteen people and has generated $2.5 million in revenue. Context Therapeutics is focused on developing novel medicines for solid tumors. Their current research centers on a selective Claudin 6 (CLDN6) bispecific antibody for CLDN6-positive tumors. This therapy is currently in preclinical development. Context Therapeutics differentiates itself through its targeted approach to cancer treatment. By focusing on CLDN6-positive tumors, they aim to develop therapies with improved efficacy and reduced side effects compared to traditional cancer treatments. For more information about Context Therapeutics, please visit www.contexttherapeutics.com.
Context Therapeutics Industry Tags
Companies Similar to Context Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to Context Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 3M | Arvada, CO | |||
| 3M | 6 | Star Valley Ranch, WY | ||
| 3M | 4 | Ann Arbor, MI | 2006 | |
| 3M | 3 | San Diego, CA | ||
| 3M | 3 | New York, NY |